Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis (NASH) Cirrhosis · MDGL

Madrigal Pharmaceuticals EU

Madrigal Pharmaceuticals EU Limited

Madrigal Pharmaceuticals EU patent portfolio — 26 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
200 Barr-Harbor Dr, Suite 200, Conshohocken, Pennsylvania 19428, US HQ
2016 Founded
1,071 Employees
Public company Type
MDGL · NYSE Ticker
Company details
Status
Public
HQ
200 Barr-Harbor Dr, Suite 200, Conshohocken, Pennsylvania 19428, US
Founded
2016
Employees
1,071
Programs
16
Drugs
11
Patents
26
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Madrigal Pharmaceuticals EU patents

26 pharmaceutical patents indexed for Madrigal Pharmaceuticals EU. 0 expire within 24 months.

Madrigal Pharmaceuticals EU has 26 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

26 patents

Patent portfolio

  1. US 12377104

    Methods for treating a fatty liver disease

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11986481

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11806353

    Methods of treating liver disorders or lipid disorders with a THR-beta agonist

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11564926

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11491145

    Combination therapies comprising targeted therapeutics

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11377447

    Targeted therapeutics

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11090308

    Methods of treating liver disorders or lipid disorders with a THR-beta agonist

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10894050

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10828315

    Targeted therapeutics

    Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10722525

    Targeted therapeutics

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10675360

    Targeted therapeutics

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10376517

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10376598

    Targeted therapeutics

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10232049

    Targeted therapeutics

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10117944

    Targeted therapeutics

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9968612

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9956293

    Targeted therapeutics

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9910031

    Compositions and methods for modulating c-Rel-dependent cytokine production

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9266861

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8115011

    Diacylglycerol acyltransferase inhibitors

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 6369127

    Material based on silicon, in particular for dental impression and method for making such material

    Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Madrigal Pharmaceuticals EU have?

26 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Madrigal Pharmaceuticals EU patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.